Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pivotal USA Randomized, Evaluator-blinded, Active-controlled, Multi-center, Split-face Comparison Study of Emervel® Deep Lidocaine Versus Juvederm® Ultra Plus in the Treatment of Moderate to Severe Facial Wrinkles and Folds

NCT01205061 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT01205061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01205061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pivotal USA Randomized, Evaluator-blinded, Active-controlled, Multi-center, Split-face Comparison Study of Emervel® Deep Lidocaine Versus Juvederm® Ultra Plus in the Treatment of Moderate to Severe Facial Wrinkles and Folds
Lead sponsor
Galderma R&D
Phase
Not applicable
Overall status
Completed
Start date
September 27, 2010
Completion date
January 12, 2012
Enrollment
162 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

skin wrinkling